1. Home
  2. MSN vs BRTX Comparison

MSN vs BRTX Comparison

Compare MSN & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Emerson Radio Corporation

MSN

Emerson Radio Corporation

HOLD

Current Price

$0.39

Market Cap

8.9M

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.15

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSN
BRTX
Founded
1948
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Managed Health Care
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
9.7M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MSN
BRTX
Price
$0.39
$1.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.3K
31.5K
Earning Date
02-13-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,739,000.00
$383,400.00
Revenue This Year
N/A
$112.14
Revenue Next Year
N/A
$139.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.70
52 Week Low
$0.28
$0.98
52 Week High
$0.85
$2.55

Technical Indicators

Market Signals
Indicator
MSN
BRTX
Relative Strength Index (RSI) 40.53 45.36
Support Level $0.38 $1.04
Resistance Level $0.42 $1.23
Average True Range (ATR) 0.02 0.08
MACD 0.00 0.02
Stochastic Oscillator 10.68 58.17

Price Performance

Historical Comparison
MSN
BRTX

About MSN Emerson Radio Corporation

Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. The products offered by the company are televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: